EPY2001 · 40411813EPY2001
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-40411813 as Adjunctive Therapy in Subjects with Focal Onset Seizures with Suboptimal Response to Levetiracetam. EudraCT Number: 2020-003698-24
Sponsor: Janssen
Phase: II
Area: Epilepsy